Scinovex
article Open AccessTop 1% cited

Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease

The FASEB Journal · 2000 · Vol. 14(7) · pp. 835–846
Robert F. MullinsStephen R. RussellDon H. AndersonGregory S. Hageman

Abstract

Age-related macular degeneration (AMD), a blinding disorder that compromises central vision, is characterized by the accumulation of extracellular deposits, termed drusen, between the retinal pigmented epithelium and the choroid. Recent studies in this laboratory revealed that vitronectin is a major component of drusen. Because vitronectin is also a constituent of abnormal deposits associated with a variety of diseases, drusen from human donor eyes were examined for compositional similarities with other extracellular disease deposits. Thirty-four antibodies to 29 different proteins or protein complexes were tested for immunoreactivity with hard and soft drusen phenotypes. These analyses provide a partial profile of the molecular composition of drusen. Serum amyloid P component, apolipoprotein E, immunoglobulin light chains, Factor X, and complement proteins (C5 and C5b-9 complex) were identified in all drusen phenotypes. Transcripts encoding some of these molecules were also found to be synthesized by the retina, retinal pigmented epithelium, and/or choroid. The compositional similarity between drusen and other disease deposits may be significant in view of the recently established correlation between AMD and atherosclerosis. This study suggests that similar pathways may be involved in the etiologies of AMD and other age-related diseases.

Retinal Diseases and TreatmentsRetinal Imaging and AnalysisGlaucoma and retinal disordersDrusenMacular degenerationVitronectinPathologyChoroidBiologyRetinalRetinal pigment epitheliumRetinaExtracellular matrix

MeSH terms

AgingAmyloidosisArteriosclerosisBase SequenceHumansImmunohistochemistryMacular DegenerationProteinsRNA, MessengerSkin DiseasesGlomerulonephritis, MembranoproliferativeRetinal DrusenDNA PrimersReverse Transcriptase Polymerase Chain Reaction

Funding

  • Research to Prevent Blindness
  • National Institutes of Health
  • NIH Office of the Director
Citations
930
FWCI
26.11
field-weighted impact
References
111
Percentile
100%
vs. same field & year
Citations per year
Cited by
Complement: a key system for immune surveillance and homeostasis
Nature Immunology · 2010 · 3,549 citations
Current Concepts in the Pathogenesis of Age-Related Macular Degeneration
Archives of Ophthalmology · 2004 · 1,001 citations
Inflammation and its role in age-related macular degeneration
Cellular and Molecular Life Sciences · 2016 · 623 citations
A role for local inflammation in the formation of drusen in the aging eye
American Journal of Ophthalmology · 2002 · 1,089 citations
Aptamers as therapeutics
Nature Reviews Drug Discovery · 2010 · 2,224 citations
The Retinal Pigment Epithelium in Visual Function
Physiological Reviews · 2005 · 2,745 citations
Related articles
A Simplified Severity Scale for Age-Related Macular Degeneration
Archives of Ophthalmology · 2005 · 791 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.